Transactions
4
Insider / ALBEMARLE CORP
Cramer Ralf Hans
Director at ALBEMARLE CORP
- Company
- ALBEMARLE CORP
- Ticker
- ALB
- First filing on record
- July 6, 2026
- Latest trade on record
- July 1, 2026
- SEC filings
- EDGAR ↗
Cramer Ralf Hans, Director at ALBEMARLE CORP, has disclosed 4 transactions in ALB since July 6, 2026: 0 purchases (0 open-market buys) and 2 sales, worth about $128K at the reported prices. The latest was filed July 6, 2026, 5 days after the trade; 4 filings were late against the 2-business-day Form 4 deadline.
Open-market buys
0
Sales
2
Avg. disclosure lag
5.0d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Cramer Ralf Hans made no purchases and 2 sales worth $128K, plus 2 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Cramer Ralf Hans has traded 1 stock on record; the largest by dollars is ALB.
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 2 | 1,286 | — |
| F | Shares withheld for tax | 2 | 942 | $128K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 4 | 0 | 2 · $128K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| ALB | Sell F | July 1, 2026 | July 6, 2026 | 5d | 13 | $136 | $1,769 | late | Form 4 ↗ | |
| ALB | Other A | July 1, 2026 | July 6, 2026 | 5d | 36 | — | — | late | Form 4 ↗ | |
| ALB | Sell F | July 1, 2026 | July 6, 2026 | 5d | 929 | $136 | $126K | late | Form 4 ↗ | |
| ALB | Other A | July 1, 2026 | July 6, 2026 | 5d | 1,250 | — | — | late | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| July 6, 2026 | Form 4 | 0001913598-26-000002 | 4 | published | EDGAR ↗ |
Other insiders at ALBEMARLE CORP
- BRLAS LAURIE Director 3 rows
- Collins Michelle T Director 2 rows
- DESALLES BARTOLOMEO EDUARDO Director 1 row
- Gagarinas Autumn M. Chief People Officer 1 row
- Hood Max Chief Accounting Officer 1 row
- MINOR GLENDA J Director 1 row
- Mummert Mark Richard Chief Operations Officer 1 row
- Norris Eric Chief Commercial Officer 1 row
- Wolff Alejandro Daniel Director 1 row
Everyone on file, with contracts and lobbying under the company's name: ALBEMARLE CORP.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 1 | 4 | July 6, 2026 | July 6, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.